Vivimed Losartan Class Action Settlement — $1.899 Million for Contaminated Blood Pressure Drug, Claim by June 2, 2026

BySteve LevinePublished: April 6, 2026TweetShareStatusClaims Openfinal approval hearing scheduled June 30, 2026Claim DeadlineJune 2, 2026Settlement Fund$1,899,000economic loss only · pro rata refund of purchase priceProof RequiredNodocumentation encouraged but not strictly required · covers 8 impacted Vivimed losartan NDCsWhat Is This Settlement About?Vivimed Life Sciences Pvt Ltd and Strides Pharma Science Limited (collectively, "Vivimed") have agreed to a $1,899,000 class action settlement to